Business Context and Reporting Period
This Form 8-K filing by Aptevo Therapeutics Inc. (APVO) was submitted on April 13, 2020, reporting events that occurred on March 26, 2020. The Company, incorporated in Delaware and listed on The Nasdaq Stock Market, is an emerging growth company focused on therapeutic development.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report is strictly informational regarding a corporate capital structure event.
Material Changes
The primary material change reported is the completion of a 1-for-14 reverse stock split effective March 26, 2020. This action resulted in the following adjustments:
- Stock Options and Warrants: Proportionate adjustments were made to per-share exercise prices and the number of shares issuable upon exercise or vesting.
- Warrant Specifics: Outstanding warrants (CUSIP# 03835L116) now have an exercise price of $18.20 (calculated as the original $1.30 multiplied by 14).
- Share Conversion: Each warrant is now exercisable for 0.07142857 shares of common stock (1 divided by 14).
- Total Warrant Shares: The outstanding warrants are now exercisable for a total of 1,417,857 shares of common stock.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of risks and contingencies beyond the notification of the stock split mechanics. The Depository Trust Company (DTC) notified warrant holders of these changes on April 13, 2020.
Investor Verification Checklist
- Verify the updated exercise price of $18.20 for outstanding warrants.
- Confirm the reduced share count of 1,417,857 available for issuance via warrants.
- Check the adjusted terms for all outstanding stock options and restricted stock units (RSUs) to ensure proportional decreases in share counts and increases in exercise prices.
- Review the Company's most recent 10-Q or 10-K for actual financial performance data, as this 8-K does not provide it.